Vitamin D and pain: Vitamin D and its role in the aetiology and maintenance of chronic pain states and associated comorbidities

Pain Research and Treatment

Volumn 2015, Issue , 2015, Pages

  Shipton, Edward A ^a   Shipton, Elspeth E ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929353314     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2015/904967     Document Type: Review

References (153)

1. M. F. Holick, "Vitamin D deficiency, "The New England Journal of Medicine, vol. 357, no. 3, pp. 266-281, 2007.
2. K. K. Deeb, D. L. Trump, and C. S. Johnson, "Vitamin D signalling pathways in cancer: potential for anticancer therapeutics, " Nature Reviews Cancer, vol. 7, no. 9, pp. 684-700, 2007.
3. T. D.Thacher and B. L. Clarke, "Vitamin D insufficiency, " Mayo Clinic Proceedings, vol. 86, no. 1, pp. 50-60, 2011.
4. K. L. Munger, L. I. Levin, B. W. Hollis, N. S. Howard, and A. Ascherio, "Serum25-hydroxyvitaminDlevels and risk ofmultiple sclerosis, " Journal of the American Medical Association, vol. 296, no. 23, pp. 2832-2838, 2006.
5. P. M. Brannon, "Key questions in Vitamin D research, " Scandinavian Journal of Clinical and Laboratory Investigation Supplementum, vol. 243, pp. 154-162, 2012.
6. G. A. Plotnikoff and J. M. Quigley, "Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain, " Mayo Clinic Proceedings, vol. 78, no. 12, pp. 1463-1470, 2003.
7. M. Cutolo, S. Paolino, A. Sulli, V. Smith, C. Pizzorni, and B. Seriolo, "Vitamin D, steroid hormones, and autoimmunity, " Annals of the New York Academy of Sciences, vol. 1317, no. 1, pp. 39-46, 2014.
8. C. A. S. Jesus, D. Feder, andM. F. P. Peres, "The role of vitamin D in pathophysiology and treatment of fibromyalgia, " Current Pain and Headache Reports, vol. 17, no. 8, p. 355, 2013.
9. J. S.Adams andM.Hewison, "Update in vitaminD, "TheJournal of Clinical Endocrinology andMetabolism, vol. 95, no. 2, pp. 471-478, 2010.
10. J. Zerwekh, "Blood biomarkers of vitaminDstatus 1, 2, 3, 4, "The American Journal of Clinical Nutrition, vol. 87, no. 4, pp. 1087S-1091S, 2008.
11. O. A. Gressner, B. Lahme, and A. M. Gressner, "Gc-globulin (vitamin D binding protein) is synthesized and secreted by hepatocytes and internalized by hepatic stellate cells through Ca2+dependent interaction with the megalin/gp330 receptor, " Clinica Chimica Acta, vol. 390, no. 1-2, pp. 28-37, 2008.
12. G. J. Atkins, P. H. Anderson, D. M. Findlay et al., "Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha, 25-dihydroxyvitamin D3, " Bone, vol. 40, no. 6, pp. 1517-1528, 2007.
13. T. E. Willnow and A. Nykjaer, "Cellular uptake of steroid carrier proteins-mechanisms and implications, "Molecular and Cellular Endocrinology, vol. 316, no. 1, pp. 93-102, 2010.
14. B.W.Hollis andC. L.Wagner, "The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes, " Journal of Clinical Endocrinology andMetabolism, vol. 98, no. 12, pp. 4619-4628, 2013.
15. H. Merskey and N. Bogduk, Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, IASP Press, Seattle, Wash, USA, 2nd edition, 1994.
16. A. Basbaum, C. Bushnell, and M. Devor, "Pain: basic mechanisms, " in Pain 2005: An Updated Review: Refresher Course Syllabus, D. Justins, Ed., pp. 3-12, IASP Press, Seattle, Wash, USA, 2005.
17. C. J. Woolf and Q. Ma, "Nociceptors-noxious stimulus detectors, " Neuron, vol. 55, no. 3, pp. 353-364, 2007.
18. P. Suchdev, "Pathophysiology of pain, " in Manual of Pain Management, C. Warfield and H. Fausett, Eds., pp. 6-10, Lippincott Williams &Wilkins, Philadelphia, Pa, USA, 2nd edition, 2002.
19. F. Porrec, "Nociceptors, the spinal dorsal horn, and descending modulation, " in Pain 2012: Refresher Courses, 14th World Congress on Pain, I. Tracey, Ed., pp. 3-14, IASP Press, Seattle, DC, USA, 2012.
20. T.W. Vanderah, "Pathophysiology of pain, " The Medical Clinics of North America, vol. 91, no. 1, pp. 1-12, 2007.
21. International Association for the Study of Pain, "Classification of chronic pain, " Pain, supplement 3, pp. S1-S226, 1986.
22. F. Seifert and C.Maihöfner, "Functional and structural imaging of pain-induced neuroplasticity, " Current Opinion in Anaesthesiology, vol. 24, no. 5, pp. 515-523, 2011.
23. A. Latremoliere and C. J. Woolf, "Central sensitization: a generator of pain hypersensitivity by central neural plasticity, " Journal of Pain, vol. 10, no. 9, pp. 895-926, 2009.
24. H. Flor, T. Elbert, S. Knecht et al., "Phantom-limb pain as a perceptual correlate of cortical reorganization following arm amputation, " Nature, vol. 375, no. 6531, pp. 482-484, 1995.
25. P. J. Siddall, "Neuroplasticity and pain: what does it all mean?" Medical Journal of Australia, vol. 198, no. 4, pp. 177-178, 2013.
26. C. Stein, "Opioids, sensory systems and chronic pain, " European Journal of Pharmacology, vol. 716, no. 1-3, pp. 179-187, 2013.
27. G.Moalem andD. J. Tracey "Immune and inflammatory mechanisms in neuropathic pain, " Brain Research Reviews, vol. 51, no. 2, pp. 240-264, 2006.
28. P. J. Siddall and M. J. Cousins, "Persistent pain as a disease entity: implications for clinical management, " Anesthesia and Analgesia, vol. 99, no. 2, pp. 510-520, 2004.
29. E. A. Shipton, "The transition from acute to chronic post surgical pain, " Anaesthesia and Intensive Care, vol. 39, no. 5, pp. 824-836, 2011.
30. C. J.Woolf, "Central sensitization: Implications for the diagnosis and treatment of pain, " Pain, vol. 152, no. 3, pp. S2-S15, 2011.
31. I. Belfer, "Nature and nurture of human pain, " Scientifica, vol. 2013, Article ID 415279, 19 pages, 2013.
32. F. M. Blyth, L. M. March, A. J. M. Brnabic, L. R. Jorm, M. Williamson, and M. J. Cousins, "Chronic pain in Australia: a prevalence study, " Pain, vol. 89, no. 2-3, pp. 127-134, 2001.
33. H. Breivik, B. Collett, V. Ventafridda, R. Cohen, and D. Gallacher, "Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment, " European Journal of Pain, vol. 10, no. 4, pp. 287-333, 2006.
34. D. Hoy, C. Bain, G. Williams et al., "A systematic review of the global prevalence of low back pain, " Arthritis and Rheumatism, vol. 64, no. 6, pp. 2028-2037, 2012.
35. A. Abdulla, N. Adams, M. Bone et al., "Guidance on the management of pain in older people, " Age and Ageing, vol. 42, supplement 1, pp. 1-57, 2013.
36. P.M. Grace, M. R. Hutchinson, S. F.Maier, and L. R. Watkins, "Pathological pain and the neuroimmune interface, " Nature Reviews Immunology, vol. 14, no. 4, pp. 217-231, 2014.
37. J. M. Teno, S.Weitzen, T.Wetle, and V. Mor, "Persistent pain in nursing home residents, "The Journal of the American Medical Association, vol. 285, no. 16, p. 2081, 2081.
38. Economics A. The High Price of Pain: The Economic Impact of Persistent Pain in Australia, MBF Foundation, 2007.
39. P. L. Kaza and T. Moulton, "Severe vitamin D deficiency in a patient with sickle cell disease: a case study with literature review, " Journal of Pediatric Hematology/Oncology, vol. 36, no. 4, pp. 293-296, 2014.
40. K. Atherton, D. J. Berry, T. Parsons, G. J. Macfarlane, C. Power, and E. Hyppönen, "Vitamin D and chronic widespread pain in a white middle-aged British population: evidence from a crosssectional population survey, " Annals of the Rheumatic Diseases, vol. 68, no. 6, pp. 817-822, 2009.
41. S. Straube, S. Derry, R. A. Moore, and H. J. McQuay, "Vitamin D for the treatment of chronic painful conditions in adults, " The Cochrane Database of Systematic Reviews, no. 1, Article ID CD007771, 2010.
42. J. Bartley, "Prevalence of vitamin D deficiency among patients attending a multidisciplinary tertiary pain clinic, " New Zealand Medical Journal, vol. 121, no. 1286, pp. 57-62, 2008.
43. M. Z. Erkal, J.Wilde, Y. Bilgin et al., "High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors, " Osteoporosis International, vol. 17, no. 8, pp. 1133-1140, 2006.
44. P. J. van Veldhuizen, S. A. Taylor, S. Williamson, and B. M. Drees, "Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength, " Journal of Urology, vol. 163, no. 1, pp. 187-190, 2000.
45. A. Lotfi, A. M. Abdel-Nasser, A. Hamdy, A. A. Omran, and M. A. El-Rehany, "Hypovitaminosis D in female patients with chronic low back pain, " Clinical Rheumatology, vol. 26, no. 11, pp. 1895-1901, 2007.
46. S. Al Faraj and K. AlMutairi, "Vitamin d deficiency and chronic low back pain in SaudiArabia, " Spine, vol. 28, no. 2, pp. 177-179, 2003.
47. G. de Torrenté de la Jara, A. Pécoud, and B. Favrat, "Female asylum seekers with musculoskeletal pain: the importance of diagnosis and treatment of hypovitaminosis D, " BioMedical Central Family Practice, vol. 7, article 4, 2006.
48. W. Huang, S. Shah, Q. Long, A. K. Crankshaw, and V. Tangpricha, "Improvement of pain, sleep, and quality of life in chronic pain patients with vitaminDsupplementation, " Clinical Journal of Pain, vol. 29, no. 4, pp. 341-347, 2013.
49. J. Iwamoto, T. Takeda, S. Ichimura, K. Matsu, and M. Uzawa, "Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis, " Journal of Orthopaedic Science, vol. 8, no. 4, pp. 532-537, 2003.
50. G. de Torrenté de la Jara, A. Pécoud, and B. Favrat, "Musculoskeletal pain in female asylum seekers and hypovitaminosis D3, " BritishMedical Journal, vol. 329, no. 7458, pp. 156-157, 2004.
51. P. Lee and R. Chen, "Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain, " Archives of Internal Medicine, vol. 168, no. 7, pp. 771-772, 2008.
52. S. Prakash, N.C.Mehta, A. S.Dabhi, O. Lakhani, M.Khilari, and N.D. Shah, "Theprevalence of headache may be related with the latitude: a possible role ofVitaminDinsufficiency?"TheJournal of Headache and Pain, vol. 11, no. 4, pp. 301-307, 2010.
53. M. Saps, C. Blank, S. Khan et al., "Seasonal variation in the presentation of abdominal pain, " Journal of Pediatric Gastroenterology and Nutrition, vol. 46, no. 3, pp. 279-284, 2008.
54. D. D. Mitsikostas, D. Tsaklakidou, N. Athanasiadis, and A. Thomas, "The prevalence of headache in Greece: correlations to latitude and climatological factors, " Headache, vol. 36, no. 3, pp. 168-173, 1996.
55. Q. Y. Zeng, R. Chen, Z. Y. Xiao et al., "Low prevalence of knee and back pain in southeast China; the Shantou COPCORD study, " The Journal of Rheumatology, vol. 31, no. 12, pp. 2439-2443, 2004.
56. H. Glerup, K. Mikkelsen, L. Poulsen et al., "Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited, " Journal of InternalMedicine, vol. 247, no. 2, pp. 260-268, 2000.
57. D. S. Arvold, M. J. Odean, M. P. Dornfeld et al., "Corelation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial, " Endocrine Practice, vol. 15, no. 3, pp. 203-212, 2009.
58. R. C. Oh and J. D. Johnson, "Chest pain and costochondritis associated with vitamin D deficiency: a report of two cases, " Case Reports in Medicine, vol. 2012, Article ID 375730, 3 pages, 2012.
59. S. Waikakul, "Serum 25-hydroxy-calciferol level and failed back surgery syndrome, " Journal of Orthopaedic Surgery (Hong Kong), vol. 20, no. 1, pp. 18-22, 2012.
60. B. N. Ames, "Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrient by triage, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 47, pp. 17589-17594, 2006.
61. L. L. Ritterhouse, S. R. Crowe, T. B. Niewold et al., "Vitamin D deficiency is associatedwith an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus, " Annals of the Rheumatic Diseases, vol. 70, no. 9, pp. 1569-1574, 2011.
62. K.Gopinath andD.Danda, "Supplementation of 1, 25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial, " International Journal of Rheumatic Diseases, vol. 14, no. 4, pp. 332-339, 2011.
63. M. Hayes, M. Yaster, J. A. Haythornthwaite et al., "Pain is a common problem affecting clinical outcomes in adults with cystic fibrosis, " Chest, vol. 140, no. 6, pp. 1598-1603, 2011.
64. N. E.West, N. Lechtzin, C. A. Merlo et al., "Appropriate goal level for 25-hydroxyvitamin D in cystic fibrosis, " Chest, vol. 140, no. 2, pp. 469-474, 2011.
65. T. L. Glover, B. R. Goodin, A. L. Horgas et al., "Vitamin D, race, and experimental pain sensitivity in older adults with knee osteoarthritis, " Arthritis & Rheumatism, vol. 64, no. 12, pp. 3926-3935, 2012.
66. G. Högberg, S. A. Gustafsson, T. Hällström, T. Gustafsson, B. Klawitter, and M. Petersson, "Depressed adolescents in a caseseries were low in vitamin D and depression was ameliorated by vitaminDsupplementation, " Acta Paediatrica, vol. 101, no. 7, pp. 779-783, 2012.
67. S. Basaran, R. Guzel, I. Coskun-Benlidayi, and F. Guler-Uysal, "Vitamin D status: effects on quality of life in osteoporosis among Turkish women, " Quality of Life Research, vol. 16, no. 9, pp. 1491-1499, 2007.
68. R. Vieth, S. Kimball, A. Hu, and P. G. Walfish, "Randomized comparison of the effects of the vitamin D3 adequate intake versus 100mcg (4000 IU) per day on biochemical responses and the wellbeing of patients, " Nutrition Journal, vol. 3, article 8, 2004.
69. V.Kunadian, G. A. Ford, B.Bawamia, W.Qiu, and J. E. Manson, "Vitamin D deficiency and coronary artery disease: a review of the evidence, " American Heart Journal, vol. 167, no. 3, pp. 283-291, 2014.
70. H. A. Bischoff-Ferrari, D. P. Kiel, B. Dawson-Hughes et al., "Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults, " Journal of Bone and Mineral Research, vol. 24, no. 5, pp. 935-942, 2009.
71. T. Penney, M. Ploughman, M.W. Austin, D. G. Behm, and J.M. Byrne, "Determining the activation of gluteus medius and the validity of the single leg stance test in chronic non-specific low back pain, " Archives of PhysicalMedicine and Rehabilitation, vol. 95, no. 10, pp. 1969-1976, 2014.
72. K. H. Cho, J. W. Beom, T. S. Lee, J. H. Lim, T. H. Lee, and J. H. Yuk, "Trunkmuscles strength as a risk factor for nonspecific low back pain: a pilot study, " Annals of Rehabilitation Medicine, vol. 38, no. 2, pp. 234-240, 2014.
73. H. A. Bischoff, H. B. Stähelin, W. Dick et al., "Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial, " Journal of Bone and Mineral Research, vol. 18, no. 2, pp. 343-351, 2003.
74. M. Pfeifer, B. Begerow, and H. W. Minne, "Vitamin D and muscle function, " Osteoporosis International, vol. 13, no. 3, pp. 187-194, 2002.
75. R. U. Simpson, G. A. Thomas, and A. J. Arnold, "Identification of 1, 25-dihydroxyvitamin: D3 receptors and activities in muscle, " The Journal of Biological Chemistry, vol. 260, no. 15, pp. 8882-8891, 1985.
76. H. A. Bischoff, M. Borchers, F. Gudat et al., "In situ detection of 1, 25-dihydroxyvitaminD3 receptor in human skeletalmuscle tissue, " The Histochemical Journal, vol. 33, no. 1, pp. 19-24, 2001.
77. O. H. Sørensen, B. Lund, B. Saltin et al., "Myopathy in bone loss of ageing: improvement by treatment with 1-hydroxycholecalciferol and calcium, " Clinical Science, vol. 56, no. 2, pp. 157-161, 1979.
78. M. Pfeifer, B. Begerow, H. W. Minne et al., "Vitamin D status, trunk muscle strength, body sway, falls, and fractures among 237 postmenopausal women with osteoporosis, " Experimental and Clinical Endocrinology & Diabetes, vol. 109, no. 2, pp. 87-92, 2001.
79. K. E.Broe, T. C. Chen, J.Weinberg, H. A. Bischoff-Ferrari, M. F. Holick, and D. P. Kiel, "A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multipledose study, " Journal of the American Geriatrics Society, vol. 55, no. 2, pp. 234-239, 2007.
80. L. Flicker, K. Mead, C. Nowson et al., "Risk factors for falls in older women in residential care in Australia, " Journal of Bone and Mineral Research, vol. 16, supplement 1, p. S170, 2001.
81. P. Geusens, C. Vandevyver, J. Vanhoof, J.-J. Cassiman, S. Boonen, and J. Raus, "Quadriceps and grip strength are related to vitaminDreceptor genotype in elderly nonobese women, " Journal of Bone andMineral Research, vol. 12, no. 12, pp. 2082-2088, 1997.
82. L. M. Shinchuk andM. F.Holick, "VitaminDand rehabilitation: improving functional outcomes, " Nutrition in Clinical Practice, vol. 22, no. 3, pp. 297-304, 2007.
83. D. A. Fernandes de Abreu, D. Eyles, and F. Féron, "Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases, " Psychoneuroendocrinology, vol. 34, supplement 1, pp. S265-S277, 2009.
84. A. V. Kalueff and P. Tuohimaa, "Neurosteroid hormone vitamin Dand its utility in clinical nutrition, " CurrentOpinion in Clinical Nutrition and Metabolic Care, vol. 10, no. 1, pp. 12-19, 2007.
85. H. H. Zakon, "The effects of steroid hormones on electrical activity of excitable cells, " Trends in Neurosciences, vol. 21, no. 5, pp. 202-207, 1998.
86. F.-S. Wu, T. T. Gibbs, and D. H. Farb, "Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor, " Molecular Pharmacology, vol. 40, no. 3, pp. 333-336, 1991.
87. A. G. Mensah-Nyagan, L. Meyer, V. Schaeffer, C. Kibaly, and C. Patte-Mensah, "Evidence for a key role of steroids in the modulation of pain, " Psychoneuroendocrinology, vol. 34, supplement 1, pp. S169-S177, 2009.
88. C. Carlberg and M. J. Campbell, "Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor, " Steroids, vol. 78, no. 2, pp. 127-136, 2013.
89. I. Neveu, P. Naveilhan, F. Jehan et al., "1, 25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells, "Molecular Brain Research, vol. 24, no. 1-4, pp. 70-76, 1994.
90. J. Brown, J. I. Bianco, J. J. McGrath, and D. W. Eyles, "1, 25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons, " Neuroscience Letters, vol. 343, no. 2, pp. 139-143, 2003.
91. S. Riaz, M. Malcangio, M. Miller, and D. R. Tomlinson, "A vitamin D3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats, " Diabetologia, vol. 42, no. 11, pp. 1308-1313, 1999.
92. E. Garcion, N. Wion-Barbot, C. N. Montero-Menei, F. Berger, and D. Wion, "New clues about vitamin D functions in the nervous system, " Trends in Endocrinology and Metabolism, vol. 13, no. 3, pp. 100-105, 2002.
93. F. Marchand, M. Perretti, and S. B. McMahon, "Role of the immune system in chronic pain, " Nature Reviews Neuroscience, vol. 6, no. 7, pp. 521-532, 2005.
94. L.McKelvey, G. D. Shorten, andG.W.O'Keeffe, "Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management, " Journal of Neurochemistry, vol. 124, no. 3, pp. 276-289, 2013.
95. C. J. Woolf, "Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain, " Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 351, no. 1338, pp. 441-448, 1996.
96. L. R. Harms, T. H. J. Burne, D. W. Eyles, and J. J. McGrath, "Vitamin D and the brain, " Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 25, no. 4, pp. 657-669, 2011.
97. L.D.Brewer, V.Thibault, K.-C.Chen, M. C. Langub, P.W.Landfield, and N. M. Porter, "Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons, " Journal of Neuroscience, vol. 21, no. 1, pp. 98-108, 2001.
98. S. J. Kiraly, M. A. Kiraly, R. D. Hawe, and N.Makhani, "Vitamin D as a neuroactive substance: review, " TheScientificWorldJournal, vol. 6, pp. 125-139, 2006.
99. R. S. Griffin, M. Costigan, G. J. Brenner et al., "Complement induction in spinal cord microglia results in anaphylatoxin C5amediated pain hypersensitivity, " Journal of Neuroscience, vol. 27, no. 32, pp. 8699-8708, 2007.
100. M. Tsuda, K. Inoue, and M. W. Salter, "Neuropathic pain and spinal microglia: a big problem from molecules in 'small' glia, " Trends in Neurosciences, vol. 28, no. 2, pp. 101-107, 2005.
101. M.Hewison, "VitaminDand the immune system: newperspectives on an old theme, " Endocrinology andMetabolism Clinics of North America, vol. 39, no. 2, pp. 365-379, 2010.
102. D. Feldman, A. Krishnan, J.Moreno, S. Swami, D.M. Peehl, and S. Srinivas, "Vitamin D inhibition of the prostaglandin pathway as therapy for prostate cancer, " Nutrition Reviews, vol. 65, no. 8, part 2, pp. S113-S115, 2007.
103. J. D. Richardson and M. R. Vasko, "Cellular mechanisms of neurogenic inflammation, " The Journal of Pharmacology and Experimental Therapeutics, vol. 302, no. 3, pp. 839-845, 2002.
104. J. J. Letterio and A. B. Roberts, "Regulation of immune responses by TGF-beta, " Annual Review of Immunology, vol. 16, pp. 137-161, 1998.
105. L. Leung and C. M. Cahill, "TNF-?and neuropathic pain-a review, " Journal of Neuroinflammation, vol. 7, article 27, 2010.
106. H. F.Deluca and M. T.Cantorna, "Vitamin D: its role and uses in immunology, " The FASEB Journal, vol. 15, no. 14, pp. 2579-2585, 2001.
107. Y. Cury, G. Picolo, V. P. Gutierrez, and S. H. Ferreira, "Pain and analgesia: the dual effect of nitric oxide in the nociceptive system, " Nitric Oxide, vol. 25, no. 3, pp. 243-254, 2011.
108. E. Garcion, L. Sindji, G. Leblondel, P. Brachet, and F. Darcy, "1, 25-dihydroxyvitamin D3 regulates the synthesis of gammaglutamyl transpeptidase and glutathione levels in rat primary astrocytes, " Journal of Neurochemistry, vol. 73, no. 2, pp. 859-866, 1999.
109. K. Takahashi, Y. Nakayama, H. Horiuchi et al., "Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha, 25-dihydroxyvitamin D3, " Immunopharmacology and Immunotoxicology, vol. 24, no. 3, pp. 335-347, 2002.
110. N. M. Perkins and D. J. Tracey, "Hyperalgesia due to nerve injury: role of neutrophils, " Neuroscience, vol. 101, no. 3, pp. 745-757, 2000.
111. J. Lemire, "1, 25-dihydroxyvitamin D3-a hormone with immunomodulatory properties, " Zeitschrift für Rheumatologie, vol. 59, supplement 1, pp. 24-27, 2000.
112. D.W. Eyles, S. Smith, R. Kinobe, M.Hewison, and J. J.McGrath, "Distribution of the vitamin D receptor and 1-hydroxylase in human brain, " Journal of Chemical Neuroanatomy, vol. 29, no. 1, pp. 21-30, 2005.
113. G. F. Jirikowski, U.W. Kauntzer, A. E. E.Dief, and J.D. Caldwell, "Distribution of vitamin D binding protein expressing neurons in the rat hypothalamus, " Histochemistry and Cell Biology, vol. 131, no. 3, pp. 365-370, 2009.
114. R. E. S. Anglin, Z. Samaan, and S. D. Walter, "Vitamin D deficiency and depression in adults: systematic review and metaanalysis, " British Journal of Psychiatry, vol. 202, no. 2, pp. 100-107, 2013.
115. S. C. Gominak andW. E. Stumpf, "The world epidemic of sleep disorders is linked to vitaminDdeficiency, " MedicalHypotheses, vol. 79, no. 2, pp. 132-135, 2012.
116. F. Baeke, T. Takiishi, H. Korf, C. Gysemans, and C. Mathieu, "Vitamin D: modulator of the immune system, " Current Opinion in Pharmacology, vol. 10, no. 4, pp. 482-496, 2010.
117. L. Imeri and M. R. Opp, "How (and why) the immune system makes us sleep, " Nature Reviews Neuroscience, vol. 10, no. 3, pp. 199-210, 2009.
118. L. Clevenger, A. Schrepf, D. Christensen et al., "Sleep disturbance, cytokines, and fatigue in women with ovarian cancer, " Brain, Behavior, and Immunity, vol. 26, no. 7, pp. 1037-1044, 2012.
119. M. R. Opp, "Cytokines and sleep, " Sleep Medicine Reviews, vol. 9, no. 5, pp. 355-364, 2005.
120. M. Opp, J. Born, andM. Irwin, "Sleep and the immune system, " in Psychoneuroimmunology, R. Ader, Ed., pp. 579-618, Elsevier Academic Press, Burlington, Mass, USA, 2007.
121. J. M. Krueger, F. J. Obál, J. Fang, T. Kubota, and P. Taishi, "The role of cytokines in physiological sleep regulation, " Annals of the New York Academy of Sciences, vol. 933, pp. 211-221, 2001.
122. M. Haack, E. Sanchez, and J. M. Mullington, "Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers, " Sleep, vol. 30, no. 9, pp. 1145-1152, 2007.
123. D. E.McCarty, A. Reddy, Q. Keigley, P. Y. Kim, andA.A.Marino, "Vitamin D, race, and excessive daytime sleepiness, " Journal of Clinical Sleep Medicine, vol. 8, no. 6, pp. 693-697, 2012.
124. K. Chopra and V. Arora, "An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets, " Expert Opinion onTherapeutic Targets, vol. 18, no. 2, pp. 159-176, 2014.
125. M. I.Maes, "Evidence for an immune response inmajor depression: a review and hypothesis, " Progress in Neuro-psychopharmacology and Biological Psychiatry, vol. 19, no. 1, pp. 11-38, 1995.
126. G. J. Summer, E. A. Romero-Sandoval, O. Bogen, O. A. Dina, S. G. Khasar, and J. D. Levine, "Proinflammatory cytokines mediating burn-injury pain, " Pain, vol. 135, no. 1-2, pp. 98-107, 2008.
127. N. Uçeyler, T. Eberle, R.Rolke, F.Birklein, andC. Sommer, "Differential expression patterns of cytokines in complex regional pain syndrome, " Pain, vol. 132, no. 1-2, pp. 195-205, 2007.
128. C. L. Raison, L. Capuron, and A. H. Miller, "Cytokines sing the blues: Inflammation and the pathogenesis of depression, " Trends in Immunology, vol. 27, no. 1, pp. 24-31, 2006.
129. Y.Dowlati, N.Herrmann, W. Swardfager et al., "A meta-analysis of cytokines in major depression, " Biological Psychiatry, vol. 67, no. 5, pp. 446-457, 2010.
130. I. J. Russell, H. Vaeroy, M. Javors, and F. Nyberg, "Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis, " Arthritis and Rheumatism, vol. 35, no. 5, pp. 550-556, 1992.
131. J. J. Mann and K. M. Malone, "Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients, " Biological Psychiatry, vol. 41, no. 2, pp. 162-171, 1997.
132. L. C. Campbell, D. J. Clauw, and F. J. Keefe, "Persistent pain and depression: a biopsychosocial perspective, " Biological Psychiatry, vol. 54, no. 3, pp. 399-409, 2003.
133. A. J. Dunn, "Effects of cytokines and infections on brain neurochemistry, " Clinical Neuroscience Research, vol. 6, no. 1-2, pp. 52-68, 2006.
134. D. Brambilla, S. Franciosi, M. R. Opp, and L. Imeri, "Interleukin-1 inhibits firing of serotonergic neurons in the dorsal raphe nucleus and enhances GABAergic inhibitory postsynaptic potentials, " European Journal of Neuroscience, vol. 26, no. 7, pp. 1862-1869, 2007.
135. A. Ellis and D. L. H. Bennett, "Neuroinflammation and the generation of neuropathic pain, " British Journal of Anaesthesia, vol. 111, no. 1, pp. 26-37, 2013.
136. P. H. Finan, B. R. Goodin, and M. T. Smith, "The association of sleep and pain: an update and a path forward, " Journal of Pain, vol. 14, no. 12, pp. 1539-1552, 2013.
137. S. González, D.Moreno-Delgado, E.Moreno et al., "Circadianrelated heteromerization of adrenergic and dopamineD4 receptors modulates melatonin synthesis and release in the pineal gland, " PLoS Biology, vol. 10, no. 6, Article IDe1001347, 2012.
138. C. A. Naranjo, L. K. Tremblay, and U. E. Busto, "The role of the brain reward system in depression, " Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 25, no. 4, pp. 781-823, 2001.
139. P. B. Wood, "Role of central dopamine in pain and analgesia, " Expert Review of Neurotherapeutics, vol. 8, no. 5, pp. 781-797, 2008.
140. P. B. Wood, "Stress and dopamine: implications for the pathophysiology of chronic widespread pain, " Medical Hypotheses, vol. 62, no. 3, pp. 420-424, 2004.
141. H. Foo and P. Mason, "Brainstem modulation of pain during sleep and waking, " SleepMedicine Reviews, vol. 7, no. 2, pp. 145-154, 2003.
142. D. C. Nascimento, M. L. Andersen, D. C. Hipólide, J. N. Nobrega, and S. Tufik, "Pain hypersensitivity induced by paradoxical sleep deprivation is not due to altered binding to brain-opioid receptors, " Behavioural Brain Research, vol. 178, no. 2, pp. 216-220, 2007.
143. O. E. Ukponmwan, J. Rupreht, and M. R. Dzoljic, "REM sleep deprivation decreases the antinociceptive property of enkephalinase-inhibition, morphine and cold-water-swim, " General Pharmacology, vol. 15, no. 3, pp. 255-258, 1984.
144. H. A. Baghdoyan, "Hyperalgesia induced by REM sleep loss: a phenomenon in search of amechanism, " Sleep, vol. 29, no. 2, pp. 137-139, 2006.
145. A.M. Kshatri, H. A. Baghdoyan, and R. Lydic, "Cholinomimetics, but not morphine, increase antinociceptive behavior from pontine reticular regions regulating rapid-eye-movement sleep, " Sleep, vol. 21, no. 7, pp. 677-685, 1998.
146. P. L. Delgado, "Depression: the case for a monoamine deficiency, " The Journal of Clinical Psychiatry, vol. 61, no. 6, pp. 7-11, 2000.
147. H. L. Fields and A. I. Basbaum, "Central nervous system mechanisms of pain modulation, " in Textbook of Pain, P. Wall and R. Melzack, Eds., pp. 243-257, Churchill Livingstone, New York, NY, USA, 1994.
148. J. Levine and Y. Taiwo, "Inflammatory pain, " in Textbook of Pain, P.Wall and R. Melzack, Eds., pp. 45-56, Churchill Livingstone, New York, NY, USA, 1994.
149. P. M. Dougherty and W. D. Willis, "Enhanced responses of spinothalamic tract neurons to excitatory amino acids accompany capsaicin-induced sensitization in themonkey, " Journal of Neuroscience, vol. 12, no. 3, pp. 883-894, 1992.
150. D. J. Claliw, "The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia, " Medical Hypotheses, vol. 44, no. 5, pp. 369-378, 1995.
151. R. Dantzer, J. C. O'Connor, G. G. Freund, R. W. Johnson, and K. W. Kelley, "From inflammation to sickness and depression: when the immune systemsubjugates the brain, " Nature Reviews. Neuroscience, vol. 9, no. 1, pp. 46-56, 2008.
152. J.W. Kasckow, D. Baker, and T. D. Geracioti Jr., "Corticotropinreleasing hormone in depression and post-traumatic stress disorder, " Peptides, vol. 22, no. 5, pp. 845-851, 2001.
153. M. Schäfer, S. A. Mousa, Q. Zhang, L. Carter, and C. Stein, "Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia, " Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 12, pp. 6096-6100, 1996.